This plain language summary describes the design of a registry to study hemolytic disease outcomes in affected families.
This article is a plain language summary of publication (PLSP) of the following article: “Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM)” by Tjoa et al published by the American Journal of Perinatology on March 20, 2026. This PLSP describes the design of the GERANIUM registry, which will collect data to help researchers understand how doctors manage hemolytic disease of the fetus and newborn (HDFN) in clinical settings. Researchers will also study outcomes related to the health and well-being of pregnant participants affected by HDFN, their children, and their families over time. This PLSP aims to help the general public, including those affected by HDFN, and health care professionals understand the design of the GERANIUM registry.
No takes yet. Share an insight, caveat, or question.
Tjoa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: